Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-012950·Benitec Biopharma Inc.
Schedule 13G ownership disclosure
Benitec Biopharma Inc
Common Stock, par value $0.0001 per share · CUSIP: 08205P209
Event date: 2024-12-31
- Filing-level shares
- 1,041,669.00
- Percent of class
- 4.5%
- HBM Healthcare Investments (Cayman) Ltd.
Shares: 1,041,669.00 · Class: 4.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-012950
- Form type
- SCHEDULE 13G/A
- Filer
- Benitec Biopharma Inc.
- CIK
- CIK 1808898
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership